Rising Dementia Rates Demand Urgent Prevention Strategies, Experts Warn
Table of Contents
- Rising Dementia Rates Demand Urgent Prevention Strategies, Experts Warn
- Italy Faces a Dementia Crisis
- Trentino’s Dementia Landscape: A Regional Snapshot
- Understanding the Spectrum of Cognitive Decline
- COVID-19’s Indirect Impact on Dementia Risk
- Young-Onset Dementia: A Growing Concern
- The Search for a Cure and Current Treatment Approaches
- Navigating the Diagnostic Pathway in Trentino
- Preparing for the Future: A Call for Preventative Action
An estimated 1.1 million peopel in Italy live with dementia, with projections indicating a significant increase in cases as the population ages. New data from the Trentino region highlights the growing challenge, emphasizing the critical need for preventative measures, starting with education.
Italy Faces a Dementia Crisis
Across Italy, nearly one million individuals also experience mild cognitive impairment (MCI), placing a substantial burden on caregivers – approximately three million nationwide. The aging demographic is a primary driver of these rising numbers, prompting calls for proactive strategies to mitigate the impact of neurodegenerative diseases.
Trentino’s Dementia Landscape: A Regional Snapshot
As of January 1, 2025, estimates for the Trentino region reveal a concerning trend: 10,572 people aged 65 and over are living with dementia. An additional 8,868 residents aged 60 and above have been diagnosed with MCI, and 224 individuals between the ages of 35 and 64 are experiencing early-onset dementia.
“It is indeed basic prevention that must start from school,” explains Dr. Raffaella di Giacopo, medical director of the Neurology Operational Unit. The increasing prevalence of dementia in Trentino, now affecting over 10,500 people, is directly linked to the region’s – and Italy’s – aging population.
Understanding the Spectrum of Cognitive Decline
Dementia encompasses a range of neurodegenerative disorders characterized by a decline in cognitive abilities severe enough to interfere with daily life. Alzheimer’s disease is the most common form, accounting for approximately 60-80% of cases. Though, other types exist, including Vascular Dementia, Lewy Body Dementia, and Fronto-Temporal Dementia.
Individuals with Fronto-Temporal Dementia often exhibit significant changes in personality, behavior, and language, alongside difficulties in understanding non-verbal cues, and interact appropriately within social contexts. Difficulties in this domain are notably associated with Fronto-Temporal Dementia.
COVID-19’s Indirect Impact on Dementia Risk
While no official estimates exist regarding the direct impact of COVID-19 on dementia rates, medical professionals have observed a concerning trend. One expert noted that the pandemic “made clear what would have manifested itself eventually, sooner or later” and contributed to an increase in psychiatric syndromes, which are known risk factors for neurodegenerative diseases.
Young-Onset Dementia: A Growing Concern
Even though dementia is primarily associated with older adults, cases of early-onset dementia – defined as onset between ages 40 and 64 – are emerging. These cases typically involve Fronto-Temporal Dementia or atypical forms of Alzheimer’s disease,manifesting as visual-spatial or language disorders. However, these instances remain less common than the classic form of Alzheimer’s.
The Search for a Cure and Current Treatment Approaches
Currently, there is no pharmacological or non-pharmacological “cure” that restores pre-morbid cognitive function. However,comprehensive “taking charge” of the patient and their caregivers – encompassing diagnosis,treatment,and ongoing care – is essential.
Promising advancements include disease-modifying therapies based on monoclonal antibodies, now available in the United States, Germany, China, and other nations, which aim to slow the progression of symptoms.
Individuals concerned about cognitive or psychiatric symptoms should first consult their general practitioner. The physician can administer a specific test (Gp-Cog) to rule out treatable causes, such as vitamin deficiencies or thyroid issues, and determine whether referral to the Cognitive Disorders and Dementia (CDC) clinic is necessary. At the CDC clinic, patients undergo comprehensive clinical evaluations, including neuropsychological testing, neuroimaging, and cerebrospinal fluid analysis, with each assessment tailored to the individual’s needs.
Preparing for the Future: A Call for Preventative Action
Healthcare services must move beyond simply tracking statistics and embrace a proactive approach focused on prevention. A recent report published in The Lancet journal in 2024 indicates that addressing 14 recognized risk factors could prevent 45% of cases of progression from MCI to dementia.
Key modifiable risk factors include low education levels, diets high in saturated fats, smoking, sedentary lifestyles, and excessive alcohol consumption. Dr. di Giacopo emphasized the importance of initiating preventative measures early in life, ideally starting in schools.
